Research libraryMitochondrial peptides and NAD+
NAD+: The Cellular Coenzyme in Laboratory Research
For laboratory research use only. The compounds discussed here are sold strictly for in vitro research. They are not drugs, supplements or cosmetics and are not for human or animal use. This article summarizes published literature for reference and is not medical or usage advice.
Ask most people what NAD+ does and you’ll get a blank stare, yet nicotinamide adenine dinucleotide may be the busiest small molecule in the cell. It works two completely different shifts. On one, it carries electrons back and forth in redox reactions. On the other, it gets eaten whole by a set of signaling enzymes. That odd double life is the reason NAD+ turns up in so much of biochemistry, and it’s where we’ll start. Every source below is linked.
What NAD+ actually is
Picture two nucleotides stuck together at their phosphates. One holds adenine, the other holds nicotinamide. That’s NAD+. The nicotinamide ring is where everything happens, grabbing a pair of electrons and then letting them go, which flips the molecule between its oxidized form (NAD+) and its reduced form (NADH). And that flipping? It runs the engine. Glycolysis needs it. So does the citric acid cycle. So does oxidative phosphorylation. Pull the NAD+/NADH pair out and energy metabolism stops cold [4].
Two jobs, not one
Now the part that’s easy to miss. Shuttling electrons isn’t NAD+’s only role. It also gets spent. Sirtuins and the poly(ADP-ribose) polymerases use it as a co-substrate, cleaving the molecule to drive what they do [1]. Think about what that means. The same molecule is a reusable electron carrier in one breath and a disposable signaling token in the next, and both draw from one shared pool. No wonder the accounting gets complicated.
How cells keep it topped up
Those consuming enzymes chew through NAD+, so cells never stop rebuilding it. The main route in mammals is the salvage pathway, which loops nicotinamide right back into fresh NAD+. The bottleneck is an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT. Revollo and colleagues found NAMPT-driven biosynthesis sets Sir2 activity, which means the side that makes NAD+ is wired straight into the side that spends it [2]. A de novo pathway and precursor routes exist too, but salvage does most of the heavy lifting [4].
What the aging studies measured
A big chunk of NAD+ research is about how its levels move over time. Reviews of the field note that NAD+ concentrations drop in tissues across the lifespan, and that this tracks with age-related changes in cell function [1]. Camacho-Pereira and colleagues went hunting for why, and found the NADase CD38 rises with age in mice and is required for the age-related NAD+ drop, working at least partly through SIRT3 [3].
Be careful here, though, because the story isn’t finished. McReynolds and colleagues reported that in aged mice, NAD+ flux held steady even though tissue concentrations were lower [5]. In other words, the amount sitting in a tissue and the rate it’s being made and used are not the same number. We cite that one on purpose. It’s a good reminder that a single measurement rarely tells the whole story.
NAD+ precursors in the literature
Most of the applied curiosity points at NAD+ precursors. One review gathered the in vivo evidence for precursor molecules that feed the salvage pathway and lift tissue NAD+ in animal models [6]. The reasoning is simple enough once you’ve seen the enzymes: if something is draining the pool, give the salvage machinery more raw material and the pool can climb back. All preclinical, mind you. For how research peptide work handles characterization and purity, see our lab-tested compounds overview.
FAQ
What’s the difference between NAD+ and NADH? They’re the oxidized and reduced forms of the same coenzyme. NAD+ takes on electrons to become NADH, NADH hands them back, and that’s how the pair carries energy [4].
Why do NAD+ levels drop with age in studies? One mapped mechanism is rising activity of the NADase CD38, which consumes NAD+ [3], though turnover can hold steady even as levels fall [5].
What enzyme controls NAD+ synthesis? NAMPT runs the rate-limiting step of the salvage pathway in mammalian cells [2].
References
- Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015. PMID 26785480
- Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004. PMID 15381699
- Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016. PMID 27304511
- Cantó C, Menzies KJ, Auwerx J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015. PMID 26118927
- McReynolds MR, Chellappa K, Chiles E, et al. NAD+ flux is maintained in aged mice despite lower tissue concentrations. Cell Syst. 2021. PMID 34559996
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018. PMID 29514064
USA-made peptides, third-party tested every batch, with the COA published for each lot.